ANIP News and Press, ANI Pharmaceuticals Inc. From 05/09/20

ANI Pharmaceuticals, Inc. (ANIP) Q1 2020 Earnings Conference Call May 7, 2020 10:30 A.M. ET Company Participants Arthur Przybyl - Chief Executive Officer Stephen Carey - Chief Financial Officer Patrick Walsh - ANI Board Member Conference Call Participants Presentation ...

Image source: The Motley Fool. ANI Pharmaceuticals Inc   (NASDAQ: ANIP) Q1 2020 Earnings Call May 8, 2020 , 8:30 p.m. ET Operator Continue reading

ANI Pharmaceuticals (NASDAQ: ANIP ): Q1 Non-GAAP EPS of $1.04 beats by $0.15 ; GAAP EPS of -$0.59 misses by $0.58 . More news on: ANI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

BAUDETTE, Minn. , May 7, 2020 /PRNewswire/ -- For the first quarter 2020, ANI reports: Net revenues of $49.8 million versus $52.9 million in 2019 GAAP net loss of $7.0 million and diluted GAAP loss per share of $0.59 Adjusted non-GAAP EBITDA of $17.6 million ...

BAUDETTE, Minn. , April 30, 2020 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its first quarter 2020 financial results on Thursday, May 7, 2020 , before the opening of the U.S. financial markets. The earnings press releas...

BAUDETTE, Minn. , April 29, 2020 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) regarding its supplemental new drug application (sNDA) for Cortrophi...

H.P. Acthar Gel is a corticotropin injection approved to treat 19 indications, including multiple sclerosis, rheumatoid arthritis, and infantile spasms. The anti-seizure drug often requires daily dosing, and only had a list price of $40 per vial in 2000. Fast forward 20 years later, the dru...

ANI Pharmaceuticals Submit Application for Relaunching Cortrophin Gel ANI Pharmaceuticals Inc. ( ANIP ) announced that it has submitted a Prior Approval Supplement to the FDA. The supplement has been filed with the Endocrinology Division of the regulatory body. The application pertains to ...

BAUDETTE, Minn. , April 14, 2020 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that Arthur S. Przybyl will depart as President and Chief Executive Officer on May 10, 2020 . The Board of Directors has retained a nationally recognized executive sea...

The FDA has accepted for review an application from ANI Pharmaceuticals ( ANIP -2.9% ) seeking approval to re-commercialize Purified Cortrophin Gel (repository corticotropin injection USP) 80U/mL. The agency's action date is July 23. More news on: ANI Pharmaceuticals, Inc., Mallinckrod...